Institutes
July 16, 2021
Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…
Blue & You Foundation for a Healthier Arkansas Awards Grants Totaling $1.95 Million for UAMS K-12 Behavioral Health Programs
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received grants totaling $1.95 million from the Blue & You Foundation for a Healthier Arkansas to support two key behavioral health programs. Arkansas Blue Cross and Blue Shield, the largest health insurer in Arkansas, established the Blue & You Foundation for a Healthier…
July 14, 2021
NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles
The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.
July 12, 2021
Helena-West Helena Native Beverly Johnson-Wells Returns to Join UAMS Rural Research Network
LITTLE ROCK — Beverly Johnson-Wells, MLS, recently returned to her hometown of Helena-West Helena to serve as associate director of research for the University of Arkansas for Medical Sciences (UAMS) Rural Research Network (RRN) and UAMS Regional Programs. Johnson-Wells will play a key part in expanding research into rural areas of Arkansas. Her role includes…
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
July 6, 2021
Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students
New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.
July 2, 2021
Departments of Geriatrics and Pediatrics Win First Place in Quality Improvement Program
Faculty from UAMS’ Departments of Geriatrics and Pediatrics garnered first place in the Quality Improvement for Advanced Learners Program (QIALP) for their exploration of racial disparity in screening methods among dementia patients.
July 1, 2021
UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders
LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…
June 29, 2021
UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic
LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
Previous page Next page